Search Results
Results found for "Andrea J Vernall"
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
Nicola J. Smith About Dr. Nicola J. Smith Dr. Nicola J Smith is an expert in molecular pharmacology with a track record in exploring GPCR structure-function Nicola J. Smith on the web UNSW Sydney LinkedIn Retraction Watch Twitter Dr.
- Dr. Paul J. Gasser | Dr. GPCR Ecosystem
Paul J. Gasser About Dr. Paul J. Paul J.
- Dr. Robert J. Lefkowitz | Dr. GPCR Ecosystem
Robert J. Well, it’s the one and only Robert J. Robert J.
- Dr. Alix A. J. Rouault | Dr. GPCR Ecosystem
J. Rouault About Dr. Alix A. J. J.
- Dr. J. Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
J. J. J. J. Silvio Gutkind on the web Dr. J Silvio Gutkind on LinkedIn Gutkind Lab – UC San Diego Moores Cancer Center Gutkind Lab publications
- Dr. Tobi Langenhan | Dr. GPCR Ecosystem
For my doctoral studies, I joined the lab of Dr Andreas Russ at the Department of Biochemistry and first
- Dr. Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
J. Silvio Gutkind sheds light on his work and life since the beginning of COVID restrictions. J. J. J Silvio Gutkind on LinkedIn Gutkind Lab on Twitter UCSD Moores Cancer Center Dr.
- Dr. Sudha Shenoy | Dr. GPCR Ecosystem
Robert J. Lefkowitz (Nobel Laureate, 2012) at Duke University. Dr.
- Brendan Wilkins | Dr. GPCR Ecosystem
now a final year PhD candidate in the Orphan Receptor Laboratory headed by Associate Professor Nicola J
- Dylan Eiger | Dr. GPCR Ecosystem
Robert J. Lefkowitz .
- Dr. Gunnar Schulte | Dr. GPCR Ecosystem
with Ernest Arenas (Karolinska Institutet, Molecular Neurobiology; 2003-2005) and later with Roger J
- Dr. Ralf Jockers | Dr. GPCR Ecosystem
Melatonin receptor » sub-committee, Editor-in-Chief of « Frontiers in Cellular Endocrinology » and AE of « J
- Dr. Andrew Tobin | Dr. GPCR Ecosystem
Andrew Tobin About Dr. Andrew Tobin Andrew Tobin studied Biochemistry at Queen Mary College, the University of London obtaining Following a post-doctoral period at Bristol Myers Squibb in Princeton USA, Andrew returned to the UK The vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma Andrew Tobin on the web University of Glasgow ResearchGate Google Scholar Twitter Dr.
- Dr. Randy Hall | Dr. GPCR Ecosystem
Keck Foundation, and the John J. Abel Award from ASPET .
- how-to-build-breakthrough-gpcr-programs | Dr. GPCR Ecosystem
Andrew Tobin draws from his experience leading translational GPCR programs and co-founding Keltic Pharma Instructor Andrew Tobin directs translational GPCR research focused on generating new medicines for brain
- Our History | Dr. GPCR Ecosystem
Robert J.
- Dr. David Sykes | Dr. GPCR Ecosystem
David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
He has also been the recipient of multiple awards, including the John J.
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
He has also been the recipient of multiple awards, including the John J.
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
He has also been the recipient of multiple awards, including the John J.
- Dr. Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
Her move from pure opioid pharmacology into migraine came from sharing a building with neurologist Andrew Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic
- Pod-Be Our Guest - Public | Dr. GPCR Ecosystem
-robert-j.-lefkowit) Dr.
- GPCR Masterclass Live Sessions | Dr. GPCR Ecosystem
Andrew Tobin | Glasgow University How to Build Breakthrough GPCR Programs Research Strategy Details May
- Dr. Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
The realization — triggered by Andrew Brown sitting with a table of actives and inactives — was that
- University | Dr. GPCR Ecosystem
Andrew Tobin | Glasgow University How to Build Breakthrough GPCR Programs Research Strategy June 4, 2026






















